Jason Aryeh Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jason Aryeh.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jason Aryeh. Jason Aryeh is Director in IMMUNOMEDICS INC ($IMMU) and Director in LIGAND PHARMACEUTICALS INC ($LGND) and Director in QLT INC/BC ($QLTI) and 10% Owner in MERRIMACK PHARMACEUTICALS INC ($MACK) and Director in Aralez Pharmaceuticals Inc. ($ARLZ).
Latest Insider Trading Transactions of Jason Aryeh
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, IMMU, LGND, MACK, NVLN, ARLZ
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 07 2021 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Option Exercise | A | 115.39 | 3,269 | 377,210 | 3,269 | |
Jun 07 2021 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Grant | A | 0.00 | 630 | 0 | 68,664 | 68 K to 68.7 K (+0.93 %) |
Jun 07 2021 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Option Exercise | A | 115.39 | 3,269 | 377,210 | 3,269 | |
Jun 07 2021 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Grant | A | 0.00 | 630 | 0 | 68,664 | 68 K to 68.7 K (+0.93 %) |
Jun 12 2020 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Option Exercise | A | 117.58 | 2,468 | 290,187 | 2,468 | |
Jun 12 2020 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Grant | A | 0.00 | 831 | 0 | 68,034 | 67.2 K to 68 K (+1.24 %) |
Sep 04 2019 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 87.01 | 750 | 65,258 | 67,203 | 66.5 K to 67.2 K (+1.13 %) |
Aug 06 2019 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 90.01 | 746 | 67,146 | 66,453 | 65.7 K to 66.5 K (+1.14 %) |
Jul 31 2019 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 93.00 | 754 | 70,122 | 65,707 | 65 K to 65.7 K (+1.16 %) |
Jul 31 2019 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 100.22 | 3,000 | 300,663 | 64,953 | 62 K to 65 K (+4.84 %) |
Jul 31 2019 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 106.01 | 250 | 26,503 | 61,953 | 61.7 K to 62 K (+0.41 %) |
Jul 18 2019 | MACK | MERRIMACK PHARMACE ... | Aryeh Jason | 10% Owner | Buy | P | 5.44 | 302 | 1,643 | 3,802 | 3.5 K to 3.8 K (+8.63 %) |
Jul 18 2019 | MACK | MERRIMACK PHARMACE ... | Aryeh Jason | 10% Owner | Buy | P | 5.44 | 302 | 1,643 | 3,802 | 3.5 K to 3.8 K (+8.63 %) |
Jul 15 2019 | MACK | MERRIMACK PHARMACE ... | Aryeh Jason | 10% Owner | Buy | P | 5.62 | 1,000 | 5,620 | 3,500 | 2.5 K to 3.5 K (+40.00 %) |
Jul 15 2019 | MACK | MERRIMACK PHARMACE ... | Aryeh Jason | 10% Owner | Buy | P | 5.71 | 2,400 | 13,704 | 2,500 | 100 to 2.5 K (+2,400.00 %) |
Jul 15 2019 | MACK | MERRIMACK PHARMACE ... | Aryeh Jason | 10% Owner | Buy | P | 5.71 | 100 | 571 | 100 | 0 to 100 |
Jun 12 2019 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 107.01 | 250 | 26,753 | 61,703 | 61.5 K to 61.7 K (+0.41 %) |
Jun 07 2019 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Option Exercise | A | 113.59 | 4,071 | 462,425 | 4,071 | |
Jun 07 2019 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Grant | A | 0.00 | 835 | 0 | 61,453 | 60.6 K to 61.5 K (+1.38 %) |
May 31 2019 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 108.51 | 500 | 54,255 | 60,618 | 60.1 K to 60.6 K (+0.83 %) |
May 31 2019 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 110.01 | 250 | 27,503 | 60,118 | 59.9 K to 60.1 K (+0.42 %) |
May 31 2019 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 111.01 | 250 | 27,753 | 59,868 | 59.6 K to 59.9 K (+0.42 %) |
May 22 2019 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 112.01 | 250 | 28,003 | 59,618 | 59.4 K to 59.6 K (+0.42 %) |
May 16 2019 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 112.51 | 250 | 28,128 | 59,368 | 59.1 K to 59.4 K (+0.42 %) |
Mar 15 2019 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 112.51 | 202 | 22,727 | 51,594 | 51.4 K to 51.6 K (+0.39 %) |
Aug 17 2018 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Sell | S | 241.81 | 26,862 | 6,495,559 | 51,392 | 78.3 K to 51.4 K (-34.33 %) |
Aug 17 2018 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Sell | S | 245.00 | 1,080 | 264,600 | 78,254 | 79.3 K to 78.3 K (-1.36 %) |
Jun 21 2018 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Option Exercise | A | 76.77 | 2,474 | 189,929 | 2,474 | |
Jun 21 2018 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Option Exercise | A | 76.77 | 2,474 | 189,929 | 2,474 | |
Jun 21 2018 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Grant | A | 0.00 | 493 | 0 | 59,118 | 58.6 K to 59.1 K (+0.84 %) |
Jun 21 2018 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Grant | A | 0.00 | 493 | 0 | 59,118 | 58.6 K to 59.1 K (+0.84 %) |
Mar 09 2018 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Sell | S | 176.48 | 4,000 | 705,899 | 79,334 | 83.3 K to 79.3 K (-4.80 %) |
Mar 09 2018 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Sell | S | 174.88 | 3,500 | 612,095 | 83,334 | 86.8 K to 83.3 K (-4.03 %) |
Feb 27 2018 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Sell | S | 155.00 | 3,417 | 529,635 | 86,834 | 90.3 K to 86.8 K (-3.79 %) |
Feb 27 2018 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Gift | G | 0.00 | 1,000 | 0 | 58,625 | 59.6 K to 58.6 K (-1.68 %) |
Nov 20 2017 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Sell | S | 140.22 | 24,400 | 3,421,368 | 90,251 | 114.7 K to 90.3 K (-21.28 %) |
Aug 25 2017 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Sell | S | 127.99 | 2,000 | 255,980 | 114,651 | 116.7 K to 114.7 K (-1.71 %) |
May 26 2017 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Option Exercise | A | 113.50 | 2,456 | 278,756 | 2,456 | |
May 26 2017 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Grant | A | 0.00 | 666 | 0 | 59,625 | 59 K to 59.6 K (+1.13 %) |
May 24 2017 | ARLZ | Aralez Pharmaceuti ... | Aryeh Jason | Director | Sell | S | 1.41 | 104,176 | 146,878 | 0 | 104.2 K to 0 (-100.00 %) |
May 24 2017 | ARLZ | Aralez Pharmaceuti ... | Aryeh Jason | Director | Sell | S | 1.42 | 233,468 | 332,365 | 104,176 | 337.6 K to 104.2 K (-69.15 %) |
May 24 2017 | ARLZ | Aralez Pharmaceuti ... | Aryeh Jason | Director | Sell | S | 1.56 | 51,041 | 79,558 | 337,644 | 388.7 K to 337.6 K (-13.13 %) |
May 17 2017 | QLTI | NOVELION THERAPEUT ... | Aryeh Jason | Director | Buy | P | 8.95 | 361 | 3,231 | 242,433 | 242.1 K to 242.4 K (+0.15 %) |
May 12 2017 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Sell | S | 111.87 | 14,582 | 1,631,334 | 116,651 | 131.2 K to 116.7 K (-11.11 %) |
May 12 2017 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Sell | S | 110.04 | 22,665 | 2,494,025 | 131,233 | 153.9 K to 131.2 K (-14.73 %) |
May 12 2017 | ARLZ | Aralez Pharmaceuti ... | Aryeh Jason | Director | Option Exercise | A | 1.56 | 15,000 | 23,400 | 15,000 | |
May 12 2017 | ARLZ | Aralez Pharmaceuti ... | Aryeh Jason | Director | Grant | A | 0.00 | 7,500 | 0 | 15,000 | 7.5 K to 15 K (+100.00 %) |
Apr 25 2017 | ARLZ | Aralez Pharmaceuti ... | Aryeh Jason | Director | Buy | P | 5.86 | 295,929 | 1,732,664 | 343,216 | 47.3 K to 343.2 K (+625.81 %) |
Feb 28 2017 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Sell | S | 107.58 | 7,000 | 753,060 | 153,898 | 160.9 K to 153.9 K (-4.35 %) |
Feb 28 2017 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Sell | S | 106.00 | 25,000 | 2,650,000 | 160,898 | 185.9 K to 160.9 K (-13.45 %) |
Jan 10 2017 | IMMU | IMMUNOMEDICS INC | Aryeh Jason | Director | Option Exercise | A | 3.73 | 22,500 | 83,925 | 22,500 | |
Dec 27 2016 | QLTI | NOVELION THERAPEUT ... | Aryeh Jason | Director | Option Exercise | A | 8.65 | 9,600 | 83,040 | 9,600 | |
Dec 01 2016 | QLTI | QLT INC/BC | Aryeh Jason | Director | Grant | A | 0.00 | 82,765 | 0 | 82,765 | 0 to 82.8 K |
Dec 01 2016 | QLTI | QLT INC/BC | Aryeh Jason | Director | Grant | A | 0.00 | 31,280 | 0 | 31,280 | 0 to 31.3 K |
Dec 01 2016 | QLTI | QLT INC/BC | Aryeh Jason | Director | Grant | A | 0.00 | 175,979 | 0 | 637,457 | 461.5 K to 637.5 K (+38.13 %) |
Dec 01 2016 | QLTI | QLT INC/BC | Aryeh Jason | Director | Grant | A | 1.76 | 1,136,363 | 1,999,999 | 1,210,363 | 74 K to 1.2 M (+1,535.63 %) |
Nov 25 2016 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Sell | S | 106.96 | 3,478 | 372,007 | 185,898 | 189.4 K to 185.9 K (-1.84 %) |
Nov 25 2016 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Sell | S | 107.40 | 15,001 | 1,611,065 | 189,376 | 204.4 K to 189.4 K (-7.34 %) |
Nov 18 2016 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Sell | S | 105.00 | 5,000 | 525,000 | 204,377 | 209.4 K to 204.4 K (-2.39 %) |
Nov 18 2016 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Sell | S | 106.33 | 1,330 | 141,419 | 209,377 | 210.7 K to 209.4 K (-0.63 %) |
Jun 21 2016 | QLTI | QLT INC/BC | Aryeh Jason | Director | Option Exercise | A | 0.00 | 12,800 | 0 | 56,800 | |
Jun 21 2016 | QLTI | QLT INC/BC | Aryeh Jason | Director | Option Exercise | A | 1.43 | 100,000 | 143,000 | 100,000 | |
Jun 20 2016 | ARLZ | Aralez Pharmaceuti ... | Aryeh Jason | Director | Option Exercise | A | 3.42 | 15,000 | 51,300 | 15,000 | |
Jun 20 2016 | ARLZ | Aralez Pharmaceuti ... | Aryeh Jason | Director | Grant | A | 0.00 | 7,500 | 0 | 7,500 | 0 to 7.5 K |
May 25 2016 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Option Exercise | A | 119.30 | 2,329 | 277,850 | 2,329 | |
May 25 2016 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Grant | A | 0.00 | 622 | 0 | 58,959 | 58.3 K to 59 K (+1.07 %) |
May 09 2016 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Sell | S | 118.52 | 15,000 | 1,777,833 | 210,707 | 225.7 K to 210.7 K (-6.65 %) |
May 09 2016 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Sell | S | 120.21 | 10,000 | 1,202,121 | 225,707 | 235.7 K to 225.7 K (-4.24 %) |
Mar 09 2016 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Sell | S | 102.49 | 500 | 51,245 | 235,707 | 236.2 K to 235.7 K (-0.21 %) |
Mar 09 2016 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Sell | S | 101.07 | 5,629 | 568,895 | 236,207 | 241.8 K to 236.2 K (-2.33 %) |
Dec 30 2015 | QLTI | QLT INC/BC | Aryeh Jason | Director | Buy | P | 2.49 | 400 | 996 | 461,478 | 461.1 K to 461.5 K (+0.09 %) |
Dec 30 2015 | QLTI | QLT INC/BC | Aryeh Jason | Director | Buy | P | 2.50 | 18,000 | 45,000 | 461,078 | 443.1 K to 461.1 K (+4.06 %) |
Nov 13 2015 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Sell | S | 101.49 | 3,000 | 304,470 | 241,836 | 244.8 K to 241.8 K (-1.23 %) |
Jul 01 2015 | QLTI | QLT INC/BC | Aryeh Jason | Director | Option Exercise | M | 3.27 | 25,000 | 81,750 | 0 | |
Jul 01 2015 | QLTI | QLT INC/BC | Aryeh Jason | Director | Option Exercise | M | 3.64 | 25,000 | 91,000 | 0 | |
Jul 01 2015 | QLTI | QLT INC/BC | Aryeh Jason | Director | Buy | M | 3.27 | 25,000 | 81,750 | 74,000 | 49 K to 74 K (+51.02 %) |
Jul 01 2015 | QLTI | QLT INC/BC | Aryeh Jason | Director | Buy | M | 3.64 | 25,000 | 91,000 | 49,000 | 24 K to 49 K (+104.17 %) |
Jun 18 2015 | QLTI | QLT INC/BC | Aryeh Jason | Director | Buy | P | 3.47 | 288,000 | 999,360 | 288,000 | 0 to 288 K |
Jun 09 2015 | QLTI | QLT INC/BC | Aryeh Jason | Director | Option Exercise | M | 0.00 | 12,000 | 0 | 0 | |
Jun 09 2015 | QLTI | QLT INC/BC | Aryeh Jason | Director | Option Exercise | M | 0.00 | 8,000 | 0 | 0 | |
Jun 09 2015 | QLTI | QLT INC/BC | Aryeh Jason | Director | Buy | M | 0.00 | 12,000 | 0 | 179,078 | 167.1 K to 179.1 K (+7.18 %) |
Jun 09 2015 | QLTI | QLT INC/BC | Aryeh Jason | Director | Buy | M | 0.00 | 8,000 | 0 | 167,078 | 159.1 K to 167.1 K (+5.03 %) |
Jun 08 2015 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Sell | S | 92.68 | 1,640 | 151,995 | 244,836 | 246.5 K to 244.8 K (-0.67 %) |
May 20 2015 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Sell | S | 87.65 | 1,000 | 87,650 | 246,476 | 247.5 K to 246.5 K (-0.40 %) |
May 20 2015 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Sell | S | 88.82 | 2,240 | 198,957 | 247,476 | 249.7 K to 247.5 K (-0.90 %) |
May 20 2015 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Sell | S | 86.74 | 6,000 | 520,440 | 249,716 | 255.7 K to 249.7 K (-2.35 %) |
Apr 27 2015 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Option Exercise | A | 89.75 | 2,754 | 247,172 | 2,754 | |
Apr 27 2015 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Grant | A | 0.00 | 925 | 0 | 58,337 | 57.4 K to 58.3 K (+1.61 %) |
Jun 02 2008 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Grant | A | 0.00 | 5,000 | 0 | 39,700 | 34.7 K to 39.7 K (+14.41 %) |
Jun 04 2007 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Option Exercise | A | 6.61 | 10,000 | 66,100 | 10,000 | |
Jun 01 2007 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 6.48 | 3,350 | 21,708 | 12,150 | 8.8 K to 12.2 K (+38.07 %) |
Jun 01 2007 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 6.48 | 5,000 | 32,400 | 29,700 | 24.7 K to 29.7 K (+20.24 %) |
Jan 05 2007 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Option Exercise | A | 3.64 | 3,781 | 13,749 | 3,781 | |
Sep 29 2006 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Option Exercise | A | 10.10 | 20,000 | 202,000 | 20,000 |
Page: 1